StreetAlpha
Climb Bio, Inc. · SEC Form 4

CLYM Insider Trading

From SEC Form 410 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Climb Bio, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $780K bought and $2.7M sold.

← CLYM stock page

Insiders are net sellers
Bought, 12 months$780K2 buys · 2 insiders
Sold, 12 months$2.7M4 sales · 2 insiders
Net−$1.9Mbought minus sold
Planned sales100%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: bought $755KDec2026-01: bought $25KJan2026-02: sold $879KFebMarAprMay2026-06: sold $407KJunJulAug2026-09: sold $1.4MSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when CLYM insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an CLYM officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

CLYM cluster buys

All CLYM cluster buys →
  • 2 insiders bought $780KTrades Dec 11, 2025 to Jan 5, 2026 · public Jan 7, 2026

A cluster buy is two or more insiders buying on the open market within 30 days of each other.

Every CLYM insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Sep 15, 2026Stephen Basil ThomasDirectorSale plan100,000$13.67$1.4M467,969Sep 17Form 4
Jun 29, 2026Aoife BrennanPresident and CEOSale plan30,902$13.17$407K87,731Jun 30Form 4
Feb 26, 2026Stephen Basil ThomasDirectorSale plan50,000$7.00$350K154,657Feb 27Form 4
Feb 13, 2026Stephen Basil ThomasDirectorSale plan100,000$5.29$529K204,657Feb 17Form 4
Jan 5, 2026RA Capital Healthcare Fund LPDirectorBuy7,111$3.50$25K3,403,429Jan 7Form 4
Dec 12, 2025Peter KolchinskyDirectorBuy314,561$2.40$755K3,396,318Dec 15Form 4
Jun 30, 2025Aoife BrennanPresident and CEOSale plan20,618$1.22$25K48,132Jul 1Form 4
Jun 20, 2025Emily PimblettSVP, Finance & CAOSale plan1,242$1.24$2K18,888Jun 20Form 4
Mar 20, 2025Emily PimblettSVP, Finance & CAOSale plan1,199$1.31$2K15,130Mar 20Form 4
Dec 19, 2024Emily PimblettChief Accounting OfficerSale plan1,235$2.02$2K11,329Dec 20Form 4

CLYM insider trading FAQ

Are CLYM insiders buying or selling?

Insiders are net sellers over the last 12 months. 2 insiders bought $780K of CLYM on the open market in 2 trades, and 2 sold $2.7M in 4 trades, 100% of that under pre-arranged trading plans.

When did an CLYM insider last buy shares?

RA Capital Healthcare Fund LP (Director) bought 7,111 shares for $25K on Jan 5, 2026, reported on Jan 7, 2026.

When did an CLYM insider last sell shares?

Stephen Basil Thomas (Director) sold 100,000 shares for $1.4M on Sep 15, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice